Skip to main content

Molecular Neurodegeneration

Articles

  1. Authors: Juan Lantero-Rodriguez, Elena Camporesi, Laia Montoliu-Gaya, Johan Gobom, Diana Piotrowska, Maria Olsson, Irena Matečko Burmann, Bruno Becker, Ann Brinkmalm, Björn M. Burmann, Michael Perkinton, Nicholas J. Ashton, Nick C. Fox, Tammaryn Lashley, Henrik Zetterberg, Kaj Blennow…

    Content type: Research article

Most recent articles RSS

View all articles

FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms
TREM2 dependent and independent functions of microglia in Alzheimer’s disease
APOE effects on regional tau in preclinical Alzheimer’s disease
Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer’s disease: review, recommendation, implementation and application
Tauopathies: new perspectives and challenges
Advances in sequencing technologies for amyotrophic lateral sclerosis research
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Solving neurodegeneration: common mechanisms and strategies for new treatments

Aims and scope

Molecular Neurodegeneration (MN) is an open access, peer-reviewed journal dedicated to publishing groundbreaking research in the field of neurodegeneration. Our mission is to foster a deeper understanding of neurodegenerative diseases, including but not limited to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, glaucoma, and macular degeneration, to inform novel diagnosis and effective therapy. We aim to publish innovative studies addressing the complex mechanisms of neurodegenerative disorders at the molecular, cellular, and systems levels, with a strong emphasis on broad impact and scientific rigor.

Collections

Glial and Vascular Contributions to Neurodegenerative Diseases

New Content Item

See Molecular Neurodegeneration's ongoing Collection on Glial and Vascular Contributions to Neurodegenerative Diseases. 

ALS: Challenges and New Advances

New Content Item

See Molecular Neurodegeneration's ongoing Collection on ALS: Challenges and New Advances.

ISMND Webinar Series

Ongoing and Past Collections

Glial and Vascular Contributions to Neurodegenerative Diseases
ALS: Challenges and New Advances
Alzheimer's Disease: Challenges for the next decade
Parkinson's Disease - A Series of Reviews
Novel Systems and Emerging Concepts
Basic biology and disease pathways


News from Alzforum

Submit manuscript

Official journal of

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 14.9
    5-year Journal Impact Factor: 16.7
    Source Normalized Impact per Paper (SNIP): 2.566
    SCImago Journal Rank (SJR): 5.205

    Speed 2023
    Submission to first editorial decision (median days): 26
    Submission to acceptance (median days): 150

    Usage 2023
    Downloads: 1,584,169
    Altmetric mentions: 2,567

Contact the Managing Editorial Team

Hongmei Li 

Lucy Job 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Molecular Neurodegeneration

ISSN: 1750-1326